Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nektar Therapeutics
AddedFeb 13, 2024
UpdatedJun 28, 2026
Nektar Therapeutics

Nektar Therapeutics

Public

Nektar Therapeutics, an American healthcare company, innovates polymer-based therapeutics.

HQ
San Francisco, CA, US
Founded
1990
Overview
Compare
Fundraising
Employees
Website

Nektar Therapeutics, founded in the United States, is dedicated to developing innovative polymer-based therapeutics. The company's core mission is to bring hope to millions of patients by creating new medicines that address serious medical needs. Nektar leverages its advanced polymer conjugate chemistry technology platform to optimize therapeutic benefits. Their product focus includes novel therapies for autoimmune disorders, chronic inflammatory conditions, and cancer, aiming to selectively modulate the immune system and restore its balance.

Notable figures affiliated with Nektar Therapeutics include key scientists and executives who have significantly contributed to the field of polymer chemistry and drug development. The company has attracted substantial investment from leading healthcare investors and has achieved several milestones, including successful clinical trials and regulatory approvals for its therapies. Nektar's impact is evident in its contribution to advancing treatment options for complex diseases, offering new hope and improved outcomes for patients worldwide.

Nektar Therapeutics - Similar Companies

NKT Therapeutics logo

NKT Therapeutics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Neurona Therapeutics logo

Neurona Therapeutics

Nerx Biosciences logo

Nerx Biosciences

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Neutrolis logo

Neutrolis

neutrolis.com

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

NeuroTherapia logo

NeuroTherapia

neurotherapia.com

Neuraptive Therapeutics logo

Neuraptive Therapeutics

neuraptive.com

Neuropathix logo

Neuropathix

neuropathix.com

Modulus Therapeutics logo

Modulus Therapeutics

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Acorda Therapeutics logo

Acorda Therapeutics

acorda.com

Nantkwest logo

Nantkwest

Nektar Therapeutics - Quick Facts

Who are Nektar Therapeutics' competitors?

Companies similar to Nektar Therapeutics include NKT Therapeutics, NeuroTherapeutics Pharma, Neurona Therapeutics and Nerx Biosciences.

When was Nektar Therapeutics founded?

Nektar Therapeutics was founded in 1990.

Where is Nektar Therapeutics' headquarters located?

Nektar Therapeutics' headquarters is located in San Francisco, CA, US.

When was Nektar Therapeutics' last funding round?

Nektar Therapeutics' most recent funding round was for $150M (USD) in February 2021.

How much has Nektar Therapeutics raised to-date?

As of Feb 17, 2021, Nektar Therapeutics has raised a total of $1.2B (USD).

How many employees does Nektar Therapeutics have?

Nektar Therapeutics has 216 employees as of Feb 6, 2024.

Nektar Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
Unique IDs
  • ein: 943134940
  • secCik: 0000906709
  • ticker: NKTR
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 423000Merchant Wholesalers, Durable Goods
  • 423400Professional and Commercial Equipment and Supplies Merchant Wholesalers
  • 423450Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
  • 420000Wholesale Trade
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5040Professional And Commercial Equipment And Supplies
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering